H-1B sponsorship profile: Aucta Pharmaceuticals Inc. Across U.S. Department of Labor LCA disclosures, Aucta Pharmaceuticals Inc filed 14 Labor Condition Applications covering 14 H-1B worker positions between fiscal year 2023 and fiscal year 2026. The employer’s DOL certification rate sits at 100% (14 certified of 14 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Aucta Pharmaceuticals Inc’s H-1B petitions range from $79,000 at the low end to $155,000 at the high end, with a petition-weighted average of $102,343. That range reflects the mix of occupations the company sponsors, led by Senior Quality Control Analyst (2 petitions at $100,000 avg), followed by Chemist and Senior Scientist. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Aucta Pharmaceuticals Inc is headquartered in Piscataway, NJ under NAICS code 325412, and places H-1B workers across 1 state, most heavily in NJ. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Aucta Pharmaceuticals Inc ranks. By H-1B petition volume, Aucta Pharmaceuticals Inc is #13,107 of 119,880 employers nationally and #1,173 of 5,818 employers headquartered in NJ. Both ranks are computed live from the same underlying petition counts, not a separate estimate.